Post-transplant diabetes: diagnosis and management

Area of Science:

• Transplantation Medicine
• Endocrinology
• Immunology

Background:

• Post-transplant diabetes mellitus (PTDM) is a frequent complication following solid organ transplantation.
• Its exact incidence remains unclear due to varied diagnostic criteria and the challenge of distinguishing it from pre-existing diabetes.
• Immunosuppressive therapies are significant contributors to PTDM development.

Purpose of the Study:

• To clarify the diagnostic criteria and management strategies for PTDM.
• To emphasize the importance of individualized care considering immunosuppressants and potential drug interactions.
• To highlight the impact of PTDM on transplant outcomes and the benefits of improved diabetes management.

Main Methods:

• Review of current international consensus guidelines for PTDM diagnosis and management.
• Application of American Diabetes Association and World Health Organization criteria, with specific considerations for post-transplant patients.
• Emphasis on a multidisciplinary team approach for patient care.

Main Results:

• Diagnosis of PTDM should be delayed until patients are on maintenance immunosuppressive doses.
• Hemoglobin A1C alone is not recommended for screening until one year post-transplant due to potential insensitivity.
• Management requires a comprehensive approach addressing glycemic control, dyslipidemia, and hypertension.

Conclusions:

• PTDM management necessitates a coordinated team effort, integrating immunosuppressant considerations.
• Improved diabetes care strategies can positively influence PTDM-related outcomes.
• Standardized diagnostic and management protocols are essential for optimizing patient care and outcomes in solid organ transplantation.